Stockreport

Hoth Therapeutics to Initiate IND Enabling Studies of HT-001 Treatment for Cancer Patients

Hoth Therapeutics, Inc.  (HOTH) 
PDF NEW YORK, Jan. 11, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced an agreement with Charles River Laboratories [Read more]